Deal Details
ASC Is Acquired by QHP
Summary
Applied StemCell, Inc. (“ASC”), has been acquired by QHP Capital, L.P. (“QHP”). Terms of the transaction were not disclosed.
Baird served as exclusive financial advisor to Applied StemCell, Inc. on this transaction.
About
Applied StemCell, Inc. is a leading cell and gene therapy CRO/CDMO focused on supporting the research community and biotechnology industry in developing and manufacturing cell and gene products. With over 15 years of gene-editing and stem cell expertise, ASC offers comprehensive and customized cell and gene CRO/CDMO solutions. ASC’s unique platform of GMP-grade allogeneic induced pluripotent stem cells (iPSC) and its proprietary TARGATT™ gene editing technology provides its clients with several advantages, including shorter manufacturing timelines, non-viral gene editing, and genomic stability and safety. ASC is headquartered in Milpitas, California.QHP Capital, L.P. invests in lower middle market healthcare companies primarily in North America, with a focus on services and technology companies where a strategic partner and operating resources can accelerate growth. Targeting companies in healthcare and pharmaceutical services industries, QHP invests in the form of buyouts, growth equity, and recapitalizations. QHP is headquartered in Raleigh, North Carolina.
CONTACT US TO LEARN MORE
- Date
- October 2023
- Company
- Applied StemCell, Inc.
- Transaction
- M&A - Sellside
- Sectors
- Healthcare
- Verticals
-
Pharmaceutical Services
- Target Geography
- North America
- Acquiror Geography
- North America
Share
